Company Overview and News

 
Neometals receives 50 cent price target from Euroz

23h proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) has received a Buy recommendation and price target of 50 cents per share from Euroz
NMT

51
Lithium demand surges along with growth in electric vehicle market

2018-09-13 proactiveinvestors.com.au - 2
Electric vehicles (EVs) represent the future of global transportation with demand expected to grow at an annual rate of 15.6% over the next five years, presenting opportunities for lithium producers.
LIT PDDTF GLN LMMFF SYA CXO DMNXF TSLA AGY NMT ARYMF

 
Neometals converts lithium residue into synthetic zeolite providing potential new revenue stream

2018-09-04 proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) has converted lithium leach residue into a valuable advanced engineered material called zeolite which provides the opportunity to add revenue to its integrated lithium strategy.
NMT

2
Vanadium Miners News For The Month Of August 2018

2018-08-29 seekingalpha
Vanadium market news - Vanadium market expected to grow, fueled by strong steel and increasing energy storage demands.
AVL SRHYY GLCNF KRC PRPCF TON NMT CCC APPPF SYR EFR AEE RDRUY ATVVF UUUU AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF CCCCF bmn

 
Neometals pursuing multiple positions in the lithium supply chain

2018-08-23 proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) is building an integrated lithium business which began with its 13.8% interest in the operating Mt Marion Lithium Mine in Western Australia.
NMT

 
Neometals to demerge titanium-vanadium assets, focus on lithium

2018-08-15 proactiveinvestors.com.au
Neometals Ltd’s (ASX:NMT) board has approved plans to demerge its Barrambie Titanium‐Vanadium Project and associated technology assets into a new ASX‐listed company.
NMT

 
Neometals’ lithium strategy gets a thumbs-up from Hallgarten & Company

2018-08-03 proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) is in full-steam-ahead mode and doing all the right things as per the research report by New York City based investment bank Hallgarten & Company.
MALRY MALRF MIN NMT ESR

2
Vanadium Miners News For The Month Of July 2018

2018-07-30 seekingalpha
Vanadium market news - Navigant - "VRB to be one of the fastest growing electrochemical storage technology sets over the next decade."
AVL SRHYY KRC PRPCF TON NMT CCC APPPF SYR EFR AEE RDRUY UUUU ATVVF AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF CCCCF bmn

1
Lithium Miners News For The Month Of July 2018

2018-07-25 seekingalpha
Lithium market - Goldman: Concerns about a wave of supply of the electric car battery material from new mines are unfounded. The selloff in companies tied to lithium is overdone.
LIT BCN PILBF LTHHF CXO SAV LAXXF LIACF AGY NMT KSN PLLLY RDRUY AZZVF WML MLNLF AIS.H KDR DFS SYA STLHF WMLLF LNRDY NGZ LMMFF GXY TAW LRS MNIKF ILHMF AMLM DMNXF MALRY BGS LACDF EEYMF MIN NMKEF ARYMF ILC GALXF MGXMF LSSCF ALTAF DJIFF NMX EMH PSC CRECF OROCF ERPNF LAC PLS FTI.WI FMC BCN TWNAF DJI RRSSF PDDTF NTTHF AVLIF MALRF ORE AVZ AJM BCRMF

 
Neometals test work able to recover high-purity titanium product

2018-07-10 proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) has received positive results from its initial metallurgical test work program at one of the top metallurgical institutes in China.
NMT

9
Vanadium Miners News For The Month Of June 2018

2018-06-29 seekingalpha - 1
Vanadium market news - "We are already in a market deficit with no known strategic stockpiles. This is only going to be further exacerbated as rebar companies begin complying."
AVL SRHYY KRC PRPCF MALRY TON MIN NMT SYR EFR AEE RDRUY UUUU ATVVF AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF MALRF bmn

1
Neometals increases Mt Edwards nickel resource to 123,340 tonnes

2018-06-25 proactiveinvestors.com.au
Neometals Ltd (ASX:NMT) has increased the nickel resource at its Mt Edwards Project in Western Australia to 7.4 million tonnes at 1.7% nickel for 123,340 tonnes of contained nickel.
NMT

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:NMT / NEOMETALS LTD on message board site Silicon Investor.

General Metals Corp. (GNMT) General Metals Corp. (GNMT) General Metals Corp. (GNMT) Nitinol Medical (NASDAQ: NMTI) Nitinol Medical (NASDAQ: NMTI) Nitinol Medical (NASDAQ: NMTI)
Numerical Technologies(NMTC): Numerical Technologies(NMTC): Numerical Technologies(NMTC): Birch Mounatin Resources, weird name for a HIGH TECH: Birch Mounatin Resources, weird name for a HIGH TECH: Birch Mounatin Resources, weird name for a HIGH TECH: